TP53 and glioblastoma: In GBM p53 mutants, the strong interaction of p62 with mutant p53/Nrf2 enhances the inhibitory effect of mutant p53 on Nrf2, thus reversing the classical p62-mediated Nrf2 activation pathway (83).